5.12
Agonisti Colinergici ad Azione Indiretta: Chimica e Relazione Struttura-Attività
Gli agonisti colinergici ad azione indiretta sono agenti che interagiscono con l'enzima acetilcolinesterasi nella fessura sinaptica, prevenendo la deg…
Gli agonisti colinergici ad azione indiretta si legano agli enzimi AChE a livello della fessura sinaptica e inibiscono l'idrolisi dell'ACh. Ciò si traduce in un aumento della concentrazione di ACh nella sinapsi, migliorando indirettamente l'azione colinergica.
In generale, sono classificati come inibitori reversibili o irreversibili in base alla loro durata d'azione.
Gli inibitori reversibili sono agenti ad azione breve e intermedia.
Gli agenti a breve durata d'azione sono alcoli semplici che riportano gruppi di ammonio quaternario come l'edrofonio.
Gli agenti ad azione intermedia includono esteri carbamici come la neostigmina e la fisostigmina.
La neostigmina è un carbammato con un gruppo ammonio quaternario, mentre la fisostigmina è un carbammato presente in natura con un gruppo amminico terziario.
Gli inibitori irreversibili includono gli organofosfati. Sono derivati dell'acido fosforico con più sostituenti, in cui uno dei sostituenti funziona come un gruppo labile.
Ad esempio, l'ecotiopato è costituito da due gruppi alcossi e un gruppo tiocolina. Il sarin, un gas nervino, ha un gruppo alcossi, uno alchilico e uno alogeno. Qui, la tiocolina e l'alogeno sono gruppi labili.
View the full transcript and gain access to JoVE Core videos
Q1: How do indirect-acting cholinergic agonists increase acetylcholine levels at the synapse?
Indirect-acting cholinergic agonists bind to acetylcholinesterase (AChE) enzymes at the synaptic cleft and inhibit the breakdown of acetylcholine into choline and acetate. By preventing ACh hydrolysis, these agents allow acetylcholine to accumulate in the synapse, indirectly enhancing cholinergic neurotransmission without directly activating cholinergic receptors.
Q2: What is the difference between reversible and irreversible cholinesterase inhibitors?
Reversible inhibitors are short- and intermediate-acting agents that temporarily bind to acetylcholinesterase, allowing enzyme recovery. Irreversible inhibitors, such as organophosphates, permanently inactivate the enzyme through covalent bonding. Reversible agents like neostigmine and physostigmine have predictable durations of action, while irreversible inhibitors produce prolonged effects.
Q3: What structural features distinguish short-acting reversible cholinesterase inhibitors?
Short-acting reversible inhibitors are simple alcohols bearing quaternary ammonium groups, exemplified by edrophonium. The quaternary ammonium moiety provides positive charge, enhancing binding to the negatively charged active site of acetylcholinesterase. This structural feature enables rapid, reversible enzyme inhibition with brief duration of action.
Q4: How do intermediate-acting agents like neostigmine and physostigmine differ structurally?
Both neostigmine and physostigmine are carbamic esters, but they differ in amine groups and origin. Neostigmine is a synthetic carbamate with a quaternary ammonium group, while physostigmine is a naturally occurring carbamate containing a tertiary amine group. These structural differences affect their pharmacokinetic properties and tissue penetration.
Q5: What makes organophosphates irreversible cholinesterase inhibitors?
Organophosphates are phosphoric acid derivatives containing multiple substituents, including a labile group that forms a covalent bond with acetylcholinesterase. Echothiophate contains two alkoxy groups and a thiocholine labile group, while sarin contains an alkoxy group, alkyl group, and halogen labile group. This covalent modification permanently inactivates the enzyme.
Q6: Why are quaternary ammonium groups important in cholinesterase inhibitor design?
Quaternary ammonium groups provide permanent positive charge, enabling strong electrostatic interactions with the negatively charged active site of acetylcholinesterase. This structural feature enhances binding affinity and specificity for the enzyme. Agents like edrophonium and neostigmine utilize quaternary ammonium moieties to achieve potent cholinesterase inhibition.
Q7: How do the labile groups in organophosphates contribute to their irreversible action?
Labile groups in organophosphates, such as the thiocholine in echothiophate or the halogen in sarin, are readily displaced during enzyme binding. This displacement allows the phosphorus atom to form a stable covalent bond with a serine residue in the acetylcholinesterase active site. The resulting phosphorylated enzyme cannot hydrolyze acetylcholine, producing irreversible inhibition.